Health Care: Drugs

Merrimack Pharmaceuticals Inc (MACK: NASDAQ)

$5.42 n/a | n/a%
12/06/16 - 09:51 AM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 89.26M 102.76M 47.79M 48.92M
Cost of Sales 46.00K 0.00 0.00 0.00
Gross Operating Profit 89.21M 102.76M 47.79M 48.92M
Selling, General, and Administrative Expenses 57.80M 30.52M 21.19M 15.80M
Research & Development 160.99M 138.50M 147.14M 125.86M
Operating Income before D & A (EBITDA) -129.57M -66.26M -120.54M -92.74M
Depreciation & Amortization 4.29M 3.22M 2.59M 3.66M
Interest Income 99.00K 114.00K 166.00K 184.00K
Other Income - Net 917.00K 813.00K 627.00K 1.36M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -132.84M -68.55M -122.34M -94.86M
Interest Expense 19.23M 18.23M 10.94M 553.00K
Pre-Tax Income -152.07M -86.78M -133.27M -95.42M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 170.00K -268.00K 240.00K -477.00K
Net Income From Continuing Operations -147.79M -83.56M -130.69M -91.75M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -147.79M -83.56M -130.69M -91.75M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -147.96M -83.29M -130.93M -91.28M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-147.79M -83.56M -130.69M -91.75M
Preferred Dividends
Net Income Available To Common -147.79M -83.56M -130.69M -91.75M
Basic EPS from Continuing Ops. -1.33 -0.80 -1.32 -1.28
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.33 -0.80 -1.32 -1.28
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.33 -0.80 -1.32 -1.28
Basic Normalized Net Income/Share -1.33 -0.80 -1.32 -1.28
EPS fr Continuing Ops. -1.33 -0.80 -1.32 -1.28
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.33 -0.80 -1.32 -1.28
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.33 -0.80 -1.32 -1.28
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.33 -0.80 -1.32 -1.28
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with MACK

Latest MACK Headlines from TheStreet

More Financial News for MACK

Press Releases for MACK

See All Press Releases

Partner Headlines for MACK

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter